Three ileus cases associated with the use of dipeptidyl peptidase‐4 inhibitors in diabetic patients

Dipeptidyl peptidase (DPP)‐4 inhibitors are a new class of antidiabetic drugs that increase incretin hormone levels to enhance blood sugar level‐dependent insulinotropic effects, suppress glucagon action, and reduce bowel motility. These incretin effects are ideal for blood sugar control. However, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanasaki, Keizo, Konishi, Kazunori, Hayashi, Ranji, Shiroeda, Hisakazu, Nomura, Tomoe, Nakagawa, Atsushi, Nagai, Takako, Takeda‐Watanabe, Ai, Ito, Hiroki, Tsuda, Shin‐ichi, Kitada, Munehiro, Fujii, Mizue, Kanasaki, Megumi, Nishizawa, Makoto, Nakano, Yasuharu, Tomita, Yasuto, Ueda, Nobuhiko, Kosaka, Takeo, Koya, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley-Blackwell 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020265/
https://www.ncbi.nlm.nih.gov/pubmed/24843724
http://dx.doi.org/10.1111/jdi.12095

Ejemplares similares

Ejemplares similares